Organogenesis Holdings Inc.
ORGONASDAQHealthcare● Active
$2.38
$-0.04(-1.65%)
Market Cap$306245424
P/E Ratio—
52W High$7.077
52W Low$2.04
Organogenesis Holdings Inc. (ORGO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ORGO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.56B | $0.48B | $0.43B | $0.45B | $0.47B |
| Cost of Revenue | $0.14B | $0.12B | $0.11B | $0.11B | $0.11B |
| Gross Profit | $0.43B | $0.37B | $0.33B | $0.35B | $0.35B |
| Gross Margin %(computed) | 75.57% | 75.99% | 75.42% | 76.71% | 75.57% |
| Operating Expenses | |||||
| R&D Expenses | $0.04B | $0.05B | $0.04B | $0.04B | $0.03B |
| G&A Expenses | $0.00B | $0.29B | $0.26B | $0.28B | $0.00B |
| Total Operating Expenses | $0.37B | $0.37B | $0.31B | $0.32B | $0.28B |
| Operating Income | $0.06B | ($0.00B) | $0.01B | $0.02B | $0.07B |
| Operating Margin %(computed) | 9.92% | -0.27% | 2.89% | 4.95% | 15.45% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.01B |
| Income Before Tax | $0.05B | ($0.00B) | $0.01B | $0.02B | $0.06B |
| Income Tax Expense | $0.01B | ($0.00B) | $0.01B | $0.00B | ($0.03B) |
| Net Income | $0.04B | $0.00B | $0.00B | $0.02B | $0.09B |
| Net Margin %(computed) | 6.58% | 0.18% | 1.14% | 3.44% | 20.16% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.16 | $-0.01 | $0.04 | $0.12 | $0.73 |
| Wtd Avg Shares | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B |
| EBITDA | $0.08B | $0.02B | $0.04B | $0.04B | $0.09B |
| EBITDA Margin %(computed) | 14.71% | 3.27% | 8.32% | 8.94% | 18.61% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Organogenesis Holdings Inc. data
About Organogenesis Holdings Inc. (ORGO) Income Statement
Organogenesis Holdings Inc. (ORGO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, ORGO reported revenue of $0.56B, gross profit of $0.43B (gross margin 75.57%), and net income of $0.04B — a net profit margin of 6.58%.
Frequently asked questions
ORGO · 4 questionsOrganogenesis Holdings Inc. (ORGO) reported revenue of $0.56B for 2025, up 16.8% year-over-year.
ORGO revenueORGO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08